Aerie Pharmaceuticals' Series A Round

Aerie Pharmaceuticals raised a round of funding on October 17, 2005.

Aerie Pharmaceuticals is a privately held, clinical-stage biotechnology company dedicated to the discovery and development of novel treatments for glaucoma. All technology of the company is based on i…

Articles about Aerie Pharmaceuticals' Series A Round: